Christopher is a Partner based in Stockholm and joined Bridgepoint in 2007. He is a member of the Technology sector team.
He currently sits on the boards of Diaverum and Vitamin Well. He has worked on a number of transactions including Vitamin Well, Evac, Nordic Cinema Group, Trustly and Terveystalo.
Prior to joining Bridgepoint he worked in the investment banking division of UBS in London where he was involved in a number of cross border transactions.
Christopher has an MSc in Business Administration and Finance from Stockholm University, School of Business.
To access investor reports through the web based reporting facility, please fill in the form to register for an account.
The information submitted on this form will be used for the sole purpose of registering you as an account user and will not be shared with third parties.